CRO Registrat-Mapi advising Trianz on ePRO development

By Nick Taylor

- Last updated on GMT

Related tags Clinical trial

Registrat-Mapi is to advise on the development of Trianz’s electronic and mobile patient reported outcome (ePRO) modules.

By collaborating with Registrat-Mapi Trianz will benefit from its experience of collecting, analysing and interpreting PRO in late phase studies. Furthermore, since 2007 Registrat-Mapi has used Trianz’s Acceliant eClinical suite for its late phase studies, giving it knowledge of the software.

Registrat-Mapi, a late phase focused contract research organisation (CRO), uses “PRO data to demonstrate product effectiveness and evidence based science​”, said Stephen Webb, the company’s president of North America.

Robust ePRO tools and web-based applications play a significant role in fulfilling these goals and successfully conducting late phase clinical trials. Contributing to the development of Trianz’s ePRO will help Registrat-Mapi ensure the software meets its requirements.

Acceliant V6.2 is due for release before the end of 2010 and incorporates a number of functional enhancements resulting from Registrat-Mapi’s input. Registrat-Mapi will continue to identify areas the ePRO modules can be improved as Trianz develops the software.

The ePRO modules support “rich set of features for patients to register, enrol and complete the necessary forms​”, said Sri Manchala, president and CEO of Trianz. Data can be captured from the internet, smartphones, tablets and interactive voice response (IVRS).

Additionally, the ePRO module provides sites with patient profiles, custom reports and real-time access to data​”, said Manchala.

Trianz demonstrated an initial version of the Acceliant ePRO module at the 2010 Annual Meeting of the Society for Clinical Data Management, which took place this week in Minneapolis, Minnesota.

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars